Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pain management

Ketamine provides short term relief from chronic migraine

A retrospective study showed that ketamine infusions improved short-term analgesia for refractory headaches

Ketamine crystals

Source: Science Photo Library

Sub-anaesthetic ketamine infusions were found to improve short-term analgesia for refractory headaches but further work is needed to determine long-term outcomes

Ketamine has shown promise in patients with chronic migraine and other intractable headaches, but requires further investigation.

Researchers carried out a retrospective study to evaluate the analgesic effects of ketamine infusions on 61 patients with refractory headaches who had been admitted to hospital for aggressive intravenous therapy.

The mean headache pain rating at admission was 7.5 ± 0.2 compared to 3.4 ± 0.3 on discharge. There was a statistically significant difference between the initial, lowest and end pain ratings.

The mean length of infusion was 5.1 days and the day of lowest pain rating was day 4. Patients achieved their lowest pain rating at mean ketamine rates of 30.8 ± 3.6mg/hour less than their pre-determined maximum dose of 1mg/kg/hour. Adverse effects were mild although one patient requested discontinuation.

Sub-anaesthetic ketamine infusions improved short-term analgesia for refractory headaches but research is needed to determine long-term outcomes, the researchers concluded at the Anesthesiology 2017 annual meeting (21 October 2017)[1].

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20204045

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Ketamine crystals

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.